Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T18:51:06.387Z.
Calculation as of: 2026-10-06T18:51:06.387Z.
Quote observation: 2026-10-06T18:50:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e7a9a1b17caad0ab37430e79e816a911291535ac0fb348029df9f580b63ef335
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Cadrenal Therapeutics, Inc. Common Stock
Market Cap
$3.67M
Free Cash Flow Yield
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD |
|---|---|---|
| Cadrenal Therapeutics, Inc. Common Stock (CVKD) | $3.67M | N/A |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.70M | N/A |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.75M | N/A |
| Evogene Ltd. (EVGN)vs › | $3.74M | N/A |
| Eocene Ltd. (EOCN)vs › | $3.57M | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.56M | N/A |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.87M | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | N/A |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A |
| Aptevo Therapeutics Inc. (APVO)vs › | $3.97M | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
